Company Filing History:
Years Active: 2012
Title: Erin E Pusateri: Innovator in MMP Inhibitors
Introduction
Erin E Pusateri is a notable inventor based in Belmont, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective hydroxamate-based MMP inhibitors. Her work focuses on addressing disorders characterized by abnormal activity of matrix metalloproteinases (MMPs).
Latest Patents
Erin holds 1 patent for her invention titled "Selective hydroxamate based MMP inhibitors." This invention provides a compound of formula (I) that acts as an inhibitor of MMP-9, MMP-12, and MMP-13. The compound can be employed for the treatment of various disorders or diseases mediated by these MMPs. Additionally, the invention includes a pharmaceutical composition that utilizes this compound.
Career Highlights
Throughout her career, Erin has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. Her experience in these organizations has contributed to her expertise in drug development and innovation.
Collaborations
Erin has collaborated with notable professionals in her field, including Thomas Leutert and Jonathan E Grob. These partnerships have likely enhanced her research and development efforts.
Conclusion
Erin E Pusateri is a distinguished inventor whose work on MMP inhibitors has the potential to impact the treatment of various diseases. Her contributions to the pharmaceutical industry reflect her commitment to innovation and improving healthcare outcomes.